Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection

Annals of Surgery

Volumn 231, Issue 2, 2000, Pages 253-261

  Göebel, Andreas ^a   Kavanagh, Eamon ^a   Lyons, Ann ^a   Saporoschetz, Inna B ^a   Soberg, Christopher ^a   Lederer, James A ^a   Mannick, John A ^a   Rodrick, Mary L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; INFECTION; INFECTION PREVENTION; INJURY; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ADULT; ANIMALS; BACTERIAL INFECTIONS; BURNS; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; MACROPHAGES; MALE; MICE; MIDDLE AGED; MONOCYTES; SPLEEN; WOUND INFECTION; WOUNDS AND INJURIES;

EID: 0343775765     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200002000-00015     Document Type: Article

References (20)

1. Deitch EA. Multiple organ failure, pathophysiology and potential future therapy. Ann Surg 1992; 216:117-134.
2. Wood JJ, Rodrick ML, O'Mahony JB, Mannick JA. Inadequate interleukin 2 production: a fundamental immunological deficiency in patients with major burns. Ann Surg 1984; 200:311.
3. Faist E, Mewes A, Strasser T, et al. Alteration of monocyte function following major injury. Arch Surg 1988; 123:287-292.
4. Decker D, Schondorf M, Bidlingmaier F, et al. Surgical stress induces a shift in the type-1/type 2 T helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery 1996; 119:316-325.
5. Ayala A, Lehman DL, Herdon CD, Chaudry IH. Mechanism of enhanced susceptibility to sepsis following hemorrhage. Arch Surg 1994; 129:1172-1178.
6. Kobayashi M, Herndon DN, Pollard RB, Suzuki F. CD4+ contra-suppressor T cells improve the resistance of thermally injured mice infected with HSV. J Leukoc Biol 1995; 58:159-167.
7. O'Sullivan ST, Lederer JA, Horgan AF, et al. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 1995; 222:482-492.
8. DiPiro JT, Howdieshell TR, Goddark JK et al. Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch Surg 1995; 130:1159-1163.
9. Mack VE, McCarter MC, Naama HA, et al. Dominance of T-helper 2-type cytokines after severe injury. Arch Surg 1996; 131:1303-1308.
10. Sherry RM, Cue JI, Goddard JK, et al. Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma 1996; 40:613-616.
11. Kelly JL, Lyons A, Soberg CC, et al. Anti-IL-10 antibody restores burn-induced defects in T-cell function. Surgery 1997; 122:246-252.
12. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-146.
13. O'Suilleabhain C, O'Sullivan ST, Kelly JL, et al. Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. Surgery 1996; 120:290-296.
14. Lyons A, Kelly JL, Rodrick ML, et al. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg 1997; 226:450-460.
15. Trinchieri G. Interleukin-12 and its role in the generation of Th1 cells. Immunol Today 1993; 14:335-337.
16. van der Poll T, Marchant A, Buurman WA, et al. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 1995; 155:5397-5401.
17. Moss NM, Gough DB, Jordan AL, et al. Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model. Surgery 1988; 104:882-887.
18. Hensler T, Heidecke C-D, Hecker H, et al. Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production. J Immunol 1998; 161:1655-1659.
19. van der Poll T, Jansen PM, Montegut WJ, et al. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J Immunol 1997; 158:1971-1975.
20. Motzer RJ, Rakhit A, Schwanz LH, et al. Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma. Clin Cancer Res 1998; 4:1183-1191.